OVAIS ZUBAIR: Open Payments
NPI 1598862567 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$797 in 34 payments from 13 companies in 2025. Trend: 2023 $296 · 2024 $670 · 2025 $797
Food & beverage: $797
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 5 | $233 |
| AstraZeneca Pharmaceuticals LP | 8 | $159 |
| Abbott Laboratories | 4 | $95 |
| Novo Nordisk Inc | 4 | $63 |
| Lilly USA, LLC | 2 | $43 |
| Globus Medical, Inc. | 1 | $37 |
| PFIZER INC. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
Products named: Leqembi, FREESTYLE LIBRE, AIRSUPRA, BREZTRI, Ozempic, Senza, REXULTI, Kerendia.
Industry payments across MO — which companies pay providers there.
